製品の概要

  • 製品名Anti-TACI antibody
    TACI 一次抗体 製品一覧
  • 製品の詳細
    Rabbit polyclonal to TACI
  • アプリケーション適用あり: WB, IHC-P, Flow Cytmore details
  • 種交差性
    交差種: Mouse, Human
    交差が予測される動物種: Chimpanzee
  • 免疫原

    Synthetic peptide:

    PELRRQRSGEVENNSDN

    , corresponding to amino acids 116-132 of Human TACI

  • ポジティブ・コントロール
    • Spleen tissue.

製品の特性

  • 製品の状態Liquid
  • 保存方法Shipped at 4°C. Upon delivery aliquot. Store at -20°C. Avoid freeze / thaw cycle.
  • バッファーPreservative: 0.05% Sodium azide
    Constituents: 99% PBS, 0.2% Gelatin
  • Concentration information loading...
  • 精製度Protein G purified
  • ポリ/モノポリクローナル
  • アイソタイプIgG
  • 研究分野

アプリケーション

Our Abpromise guarantee covers the use of ab79023 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
WB
IHC-P
Flow Cyt
  • 追加情報Flow Cyt: Use at an assay dependent dilution.
    IHC-P: Use at a concentration of 5 µg/ml.
    WB: Use at a concentration of 5 µg/ml. Predicted molecular weight: 32 kDa.

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • ターゲット情報

    • 機能Receptor for TNFSF13/APRIL and TNFSF13B/TALL1/BAFF/BLYS that binds both ligands with similar high affinity. Mediates calcineurin-dependent activation of NF-AT, as well as activation of NF-kappa-B and AP-1. Involved in the stimulation of B- and T-cell function and the regulation of humoral immunity.
    • 組織特異性Highly expressed in spleen, thymus, small intestine and peripheral blood leukocytes. Expressed in resting B-cells and activated T-cells, but not in resting T-cells.
    • 関連疾患Defects in TNFRSF13B are the cause of immunodeficiency common variable type 2 (CVID2) [MIM:240500]. CVID2 is a primary immunodeficiency characterized by antibody deficiency, hypogammaglobulinemia, recurrent bacterial infections and an inability to mount an antibody response to antigen. The defect results from a failure of B-cell differentiation and impaired secretion of immunoglobulins; the numbers of circulating B cells is usually in the normal range, but can be low.
      Defects in TNFRSF13B are a cause of immunoglobulin A deficiency 2 (IGAD2) [MIM:609529]. Selective deficiency of immunoglobulin A (IGAD) is the most common form of primary immunodeficiency, with an incidence of approximately 1 in 600 individuals in the western world. Individuals with symptomatic IGAD often have deficiency of IgG subclasses or decreased antibody response to carbohydrate antigens such as pneumococcal polysaccharide vaccine. Individuals with IGAD also suffer from recurrent sinopulmonary and gastrointestinal infections and have an increased incidence of autoimmune disorders and of lymphoid and non-lymphoid malignancies. In vitro studies have suggested that some individuals with IGAD have impaired isotype class switching to IgA and others may have a post-switch defect. IGAD and CVID have been known to coexist in families. Some individuals initially present with IGAD1 and then develop CVID. These observations suggest that some cases of IGAD and CVID may have a common etiology.
    • 配列類似性Contains 2 TNFR-Cys repeats.
    • 細胞内局在Membrane.
    • Information by UniProt
    • 参照データベース
    • 別名
      • CD 267 antibody
      • CD267 antibody
      • CD267 antigen antibody
      • CVID antibody
      • CVID2 antibody
      • FLJ39942 antibody
      • MGC133214 antibody
      • MGC39952 antibody
      • OTTHUMP00000065442 antibody
      • TNFRSF 13B antibody
      • TNFRSF 14B antibody
      • TNFRSF13B antibody
      • TNFRSF13B protein antibody
      • TNFRSF14B antibody
      • TR13B_HUMAN antibody
      • Transmembrane activator and CAML interactor antibody
      • Tumor necrosis factor receptor 13B antibody
      • Tumor necrosis factor receptor superfamily member 13B antibody
      see all

    Anti-TACI antibody 画像

    • Immunohistochemical analysis of formalin-fixed, paraffin-embedded Human spleen tissue, staining TACI with ab79023 at 5 µg/ml.
    • Anti-TACI antibody (ab79023) at 0.1 µg/ml + Daudi cell lysate at 10 µg

      Predicted band size : 32 kDa

    Anti-TACI antibody (ab79023) 使用論文

    ab79023 has not yet been referenced specifically in any publications.

    Product Wall

    I am sorry to hear that you have experienced difficulties with two of our products in the past. However, because we carry over 90,000 products, it isn't feasible for us to keep small sample sizes of our products.
    We are happy to reassure our custo...

    Read More

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"